StemProtein, LLC.

StemProtein was founded in 2014 as a subsidiary of Stemedica Cell Technologies, Inc. We manufacture Stem Cell Factors (SCFs) that include proteins, polysaccharides, and membrane-enclosed vesicles carrying RNA molecules involved in gene regulation. We manufacture these factors in a heat-stable form that does not require refrigeration. StemProtein manufactures Stem Cell Factors (SCFs) from ischemic-tolerant mesenchymal stem cells and other proprietary and innovative cell lines in a powder form for pharmaceutical use in a wide range of preventative, health-maintenance, and treatment products, including nasal sprays, eye drops, intravenous injections, wound dressings, and creams. It is our mission to improve quality of life for all individuals, young and old, by providing a unique and beneficial clinically-tested product. Our Stem Cell Factors (SCFs) contain biologicals that have a valuable therapeutic effect in a wide range of tissue processes including tissue regeneration, new blood vessel formation (angiogenesis and cell differentiation), prevention of cell death, and inhibition of collagenases (anti-scarring and anti-apoptotic effects). We test our Stem Cell Factors (SCFs) for sterility and endotoxin throughout the manufacturing process. After final packaging, SCFs undergo terminal sterilization by electron beam radiation. A high dose of radiation (≥25 kGy) eliminates all concerns regarding transmission of small viruses that may pass through 200 nm bacterial filters. We currently develop several formulations containing heat stable SCFs: wound dressings, mucoadhesive films and tablets, eye drops, nasal sprays, and a number of skin care products.